Justin A Ezekowitz
Overview
Explore the profile of Justin A Ezekowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
354
Citations
9136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zampieri F, Rathwell S, McAlister F, Ross H, Escobedo J, Saldarriaga C, et al.
J Card Fail
. 2025 Mar;
PMID: 40043831
Objectives: Explore the presence of heterogeneity in treatment effects (HTE) in the Study of Dietary Intervention of Sodium Under100 mmol in Heart Failure (SODIUM-HF) trial using a risk-effect-based approach. Background:...
2.
Saldarriaga C, Zannad F, McMullan C, Xing A, Gates D, Anstrom K, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39956649
Aims: To describe the baseline characteristics of the participants in the VICTOR (Vericiguat Global Study in Patients with Chronic Heart Failure; NCT05093933) trial and compare them to recent trials in...
3.
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial
Ezekowitz J, Mulder H, Mentz R, Butler J, DE Pasquale C, Lewis G, et al.
J Card Fail
. 2025 Jan;
PMID: 39890013
Background: The HEART-FID trial (Randomized Placebo-Controlled Trial of Ferric Carboxymaltose [FCM] as Treatment for Heart Failure with Iron Deficiency) is the largest trial to test intravenous iron (ferric carboxymaltose [FCM])...
4.
Tang W, Liu Y, Butler J, Del Prato S, Ezekowitz J, Ibrahim N, et al.
Circ Heart Fail
. 2025 Jan;
:e012200.
PMID: 39882614
Background: Objective indices of functional capacity in patients with diabetic cardiomyopathy and stage B heart failure (HF) have not been comprehensively defined. We sought to characterize the cardiopulmonary exercise characteristics...
5.
Siddiqi T, Packer M, Ezekowitz J, Fonarow G, Greene S, Kittleson M, et al.
JACC Heart Fail
. 2025 Jan;
13(1):14-27.
PMID: 39779178
Several trials have evaluated diuretic-based strategies to improve symptoms and outcomes in patients with acute heart failure (AHF). The authors sought to summarize the effect of different combination strategies on...
6.
Zhou K, Alemayehu W, Rathwell S, McAlister F, Ross H, Escobedo J, et al.
Am Heart J
. 2024 Dec;
281:49-58.
PMID: 39643096
Background: SODIUM-HF was a large clinical trial testing dietary sodium restriction compared to usual care in patients with heart failure that showed no reduction in clinical events. It has been...
7.
Zampieri F, Ezekowitz J
Can J Cardiol
. 2024 Nov;
PMID: 39536916
Clinical trials in acute care settings, particularly those involving small populations or high mortality contexts, present unique challenges in design and analysis. In this review we explore novel statistical approaches...
8.
Reddy Y, Butler J, Anstrom K, Blaustein R, Bonaca M, Corda S, et al.
Eur J Heart Fail
. 2024 Oct;
27(2):209-218.
PMID: 39473305
Aims: In the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial, the soluble guanylate cyclase stimulator vericiguat reduced the risk of hospitalization for heart...
9.
Fine N, Kalmady S, Sun W, Greiner R, Howlett J, White J, et al.
PLOS Digit Health
. 2024 Oct;
3(10):e0000636.
PMID: 39453878
Aims: Patients visiting the emergency department (ED) or hospitalized for heart failure (HF) are at increased risk for subsequent adverse outcomes, however effective risk stratification remains challenging. We utilized a...
10.
Kittipibul V, Mentz R, Young R, Butler J, Ezekowitz J, Lam C, et al.
ESC Heart Fail
. 2024 Oct;
PMID: 39434631
Aims: The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high-risk HF. This...